Defunct Company
Total Trials
4
As Lead Sponsor
1
As Collaborator
3
Total Enrollment
3,236
NCT01871142
Evaluation of the Attenuation by Aes-103 of Hypoxia Mediated Decrements in Endurance Exercise Performance
Phase: Phase 1/2
Role: Collaborator
Start: Mar 31, 2013
Completion: Jun 30, 2014
NCT05196477
Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection
Phase: N/A
Start: Jul 14, 2021
Completion: Aug 29, 2022
NCT05277194
Reducing Challenging Behaviors in Children With Autism Through Digital Health
Start: Sep 26, 2023
Completion: Jun 30, 2025
NCT07151950
Obi Medical Robot: Evaluating Effectiveness Related to Usability
Role: Lead Sponsor
Start: May 10, 2025
Completion: Oct 31, 2025